Author: <span>Walter Pacheco</span>
asbestos exposure, Legal, Mesothelioma News

J&J Must Stop Claiming Plaintiff Support of $8.9B Talc Settlement

 

A federal bankruptcy judge ordered a lawyer for Johnson & Johnson to stop making unsubstantiated claims about support for an $8.9 billion settlement for talc victims without being able to back them up.  The order came during a multiday court hearing in late June in Trenton, New Jersey. Plaintiffs’ attorneys investigated Johnson & Johnson’s public […]

The post J&J Must Stop Claiming Plaintiff Support of $8.9B Talc Settlement appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma News

Mesothelioma Clinical Trial Testing New INBRX-109 Antibody

 

A new clinical trial is testing an innovative approach to immunotherapy that could change the way antibodies target pleural mesothelioma tumors. Researchers at eight cancer centers across the U.S. are examining the safety and efficacy of INBRX-109, a unique antibody structure developed to bind with and destroy mesothelioma tumor cells without harming healthy tissue. Enrollment…

The post Mesothelioma Clinical Trial Testing New INBRX-109 Antibody appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma News

Mesothelioma Study Explores New Treatment When Chemotherapy Fails

 

A clinical trial is exploring whether a novel immunotherapy/antiangiogenic combination can serve as an effective second-line treatment for pleural mesothelioma. Early indications of the four-center, phase II clinical trial are positive. The combination involves nivolumab (Opdivo) , a well-known immunotherapy drug, and ramucirumab (Cyramza), a therapy drug that blocks the formation of blood vessels needed…

The post Mesothelioma Study Explores New Treatment When Chemotherapy Fails appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma News

Baylor Opens New Immunotherapy Clinical Trial for Mesothelioma

 

The Baylor College of Medicine in Houston has opened its latest clinical trial for mesothelioma patients to study the effectiveness of a novel immunotherapy combination. The nonsurgical, single-center study is looking for a dozen patients whose pleural mesothelioma has progressed after at least one regimen of chemotherapy. The phase II clinical trial involves Opdivo (nivolumab)…

The post Baylor Opens New Immunotherapy Clinical Trial for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma News

Mesothelioma Treatment in Toronto Moves from SMART to SMARTER

 

The Princess Margaret Cancer Center in Toronto has moved from SMART to SMARTER with the recent launch of its latest clinical trial for pleural mesothelioma patients. SMARTER is the acronym for Surgery for Mesothelioma After Radiation Therapy using Extensive pleural Resection, which also describes the latest clinical trial. The phase I clinical trial is an…

The post Mesothelioma Treatment in Toronto Moves from SMART to SMARTER appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Mesothelioma News

J&J Faces Criminal Probe over Asbestos in Baby Powder

 

The U.S. Justice Department is conducting a criminal investigation to determine if Johnson & Johnson misled the public about the possible presence of asbestos fibers and the resulting cancer risk in its talcum powder. According to Bloomberg News, a federal grand jury is examining whether company officials knew and denied their product once contained trace…

The post J&J Faces Criminal Probe over Asbestos in Baby Powder appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

bap1 gene mutation, john a burns school of medicine, mesothelioma grants, Mesothelioma News, mesothelioma research grant, mesothelioma vaccine, pietro bertino, university of hawaii cancer center

Mesothelioma Vaccine Aims to Stop Cancer Before It Begins

 

Dr. Pietro Bertino can envision a time when mesothelioma cancer no longer exists. He can see it through the work he does every day. Bertino is an assistant researcher in the Cell and Molecular Biology Department at the John A. Burns School of Medicine at the University of Hawaii. The U.S. Department of Defense awarded…

The post Mesothelioma Vaccine Aims to Stop Cancer Before It Begins appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

heating cancer tumors, Mesothelioma News, mesothelioma treatments, new mesothelioma treatments, treating cancer with carbon nanotubes, treating peritoneal mesothelioma, treating pleural mesothelioma

Heating Tumors May Improve Mesothelioma Treatments

 

A recent study shows heating malignant tumors could improve treatments for mesothelioma and other cancers. Researchers in France successfully softened malignant tumors by heating them, a process known as nanohyperthermia, which altered the collagen fibers and reduced the rigidity and volume of the tumors, making them more susceptible to chemotherapy and other therapeutic treatments. Malignant…

The post Heating Tumors May Improve Mesothelioma Treatments appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

heating cancer tumors, Mesothelioma News, mesothelioma treatments, new mesothelioma treatments, treating cancer with carbon nanotubes, treating peritoneal mesothelioma, treating pleural mesothelioma

Heating Tumors May Improve Mesothelioma Treatments

 

A recent study shows heating malignant tumors could improve treatments for mesothelioma and other cancers. Researchers in France successfully softened malignant tumors by heating them, a process known as nanohyperthermia, which altered the collagen fibers and reduced the rigidity and volume of the tumors, making them more susceptible to chemotherapy and other therapeutic treatments. Malignant…

The post Heating Tumors May Improve Mesothelioma Treatments appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

doctor ka-kit hui at ucla, east west medicine, integrative medicine for mesothelioma, International Symposium on Malignant Mesothelioma, Mesothelioma News, Mesothelioma Research

Mesothelioma Patients Benefit from Integrative Medicine Expert

 

Dr. Ka-Kit Hui is no expert on mesothelioma cancer, but he helps mesothelioma patients live longer and better lives every day. Committed to teaching the benefits of integrative medicine, Hui’s vision blends the best of traditional Chinese and conventional Western medicines, skillfully bridging the gap between the two. He launched the UCLA Center for East-West…

The post Mesothelioma Patients Benefit from Integrative Medicine Expert appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

early detection of mesothelioma, early diagnosis of mesothelioma, early mesothelioma diagnosis, hmgb1 isoforms, malignant pleural mesothelioma, Mesothelioma News, Mesothelioma Research, mesothelioma survival

Early Detection of Mesothelioma Lies in HMGB1 Isoforms

 

An international research team is exploring how variants of an important blood protein could be the key to prevention and early detection of malignant mesothelioma. Dr. Haining Yang at the University of Hawaii Cancer Center is leading the research and recently presented potential strategies at the 6th International Symposium on Malignant Pleural Mesothelioma. Previously, Yang…

The post Early Detection of Mesothelioma Lies in HMGB1 Isoforms appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

asbestos ban, asbestos ban in canada, asbestos deaths in canada, asbestos in canada, justin trudeau asbestos ban, mesothelioma in canada, Mesothelioma News

Canada Will Ban Asbestos by 2018

 

After the latest push from unions and federal labor advocates, the Canadian government is moving to ban asbestos by 2018. Science Minister Kirsty Duncan announced the long-awaited news in late December. The ban will apply to the manufacture of any products containing asbestos, as well as imports made with the deadly mineral. It could be…

The post Canada Will Ban Asbestos by 2018 appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

chemotherapy for mesothelioma, cuban lung cancer vaccine, enpro settlement, garlock settlement, johnny lattner dead, johnny lattner dies of cancer, johnny lattner mesothelioma, lung cancer cinevax, lung cancer vaccine, mesothelioma clinical trials, Mesothelioma News, Mesothelioma treatment, mesothelioma treatment news, mr fluffy asbestos, mr fluffy homes in australia, quincy jones cancer, quincy jones comedian, quincy jones mesothelioma, top 10 cancer news, top 10 mesothelioma news, top 10 news

Top 10 Mesothelioma News Stories of 2016

 

Mesothelioma researchers, advocates and physicians unite across the nation every day to change the future of mesothelioma treatment. Because of their selfless efforts, mesothelioma survivors are living longer, fuller lives with their loved ones at their side. As an advocacy organization, we continually share the latest news about medical breakthroughs and other advancements impacting the…

The post Top 10 Mesothelioma News Stories of 2016 appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Baylor College of Medicine, chemotherapy for mesothelioma, Dr. David Sugarbaker, mesothelioma chemotherapy drugs, mesothelioma clinical trial, Mesothelioma News, mesothelioma treatment center at baylor

Sugarbaker Touts New Clinical Study for Mesothelioma Patients

 

The Mesothelioma Treatment Center at the Baylor College of Medicine Lung Institute has opened a groundbreaking clinical trial combining cytoreductive surgery with a hyperthermic, intraoperative chemotherapy lavage. Dr. David Sugarbaker, chief of thoracic surgery at Baylor and one of the world’s foremost authorities on pleural mesothelioma, believes the study could lead to a major advancement…

The post Sugarbaker Touts New Clinical Study for Mesothelioma Patients appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

chemotherapy clinical trial, chemotherapy for mesothelioma, extending mesothelioma survival, Mesothelioma News, Mesothelioma treatment, nintedanib

Mesothelioma Trial for Nintedanib Shows Positive Results

 

Researchers have reported more promising results from an international, multicenter phase II clinical trial of the drug nintedanib, moving it another step closer to standard-of-care treatment for pleural mesothelioma. Nintedanib is a small-molecule enzyme inhibitor being studied as a way to increase the effectiveness of chemotherapy on mesothelioma and certain types of lung cancer. Researchers…

The post Mesothelioma Trial for Nintedanib Shows Positive Results appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.